Stowal,
If you could find out for us whether his Gleason 7 is of the (3+4) type or the (4+3) type we could help a bit more. A Gleason 7 is always a mix of two Gleason "grades" which describe the two types of cancer cell patterns that were seen under the microscope. Gleason 7 (3+4) has more of the less-aggressive grade 3 pattern cells and fewer of the more aggressive grade 4 pattern cells. Gleason 7(4+3) has more of the bad (grade 4 cells). Gleason 7(4+3) is worse than Gleason 7(3+4). On the other hand neither of them is as bad as my Gleason 9(4+5) and I'm doing OK, so not to worry excessively.
The thing is a lot of the therapy decisions, for surgery and for radiation, divide between Gleason 7(3+4) and Gleason 7(4+3). To treat the (4+3) kind doctors will add more to the treatments -- more aggressive treatments for more aggressive cancers. Often this extra treatment that comes with the higher risk are in the form of hormone therapy added to surgery or radiation or a second kind of radiation added in with radioactive seeds.
The two things you said about
surgery are sort of true but need to be taken in context. Surgery is better for younger men, when compared to surgery for older men. For really old men this can get so extreme that even the surgeons will admit that radiation would probably do better. So for older men one typically doesn't consider surgery but for younger men one does.
And yes, the side effects of surgery hit a man immediately and then, hopefully get better while the side effects of radiation come on gradually, as do most of the side effects of hormone therapy. Its probably true that, on average, after all the improvements a man makes after surgery have happened, and after the late-breaking problems of radiation have occurred, the radiation guys are probably still a bit better off, on average, although men treated by rock-star surgeons may do better yet.
And now, if you will excuse me I will quibble with Tall Allen who knows much more than I do.
Tall One.
Your study's abstract said...
Biochemical recurrence was denoted as 1) adjuvant therapy or 2) 2 prostate specific antigen values above 0.2 ng/ml. Biochemical recurrence-free survival, and patient and tumor characteristics were investigated.
One of the advantages I see to surgery is that it allows for a mid-course correction. That's the flip side of the "assurance" you get when things go well. I consider surgery plus adjuvant therapy to be one combined treatment. If I understand the wording right I would be considered to have had a biochemical recurrence despite two years of undetectable PSAs. Seems odd.